Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 13.53
-0.10 (-0.70%)
Jul 27, 2026, 3:27 PM GMT
Creo Medical Group Revenue
In the year 2025, Creo Medical Group had annual revenue of 6.00M GBP with 50.00% growth. Creo Medical Group had revenue of 3.80M in the half year ending December 31, 2025, a decrease of -74.83%.
Revenue
6.00M
Revenue Growth
+50.00%
P/S Ratio
10.29
Revenue / Employee
57.69K
Employees
104
Market Cap
61.76M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.00M | 2.00M | 50.00% |
| Dec 31, 2024 | 4.00M | - | - |
| Dec 31, 2023 | 4.00M | -23.20M | -85.29% |
| Dec 31, 2022 | 27.20M | 2.04M | 8.10% |
| Dec 31, 2021 | 25.16M | 15.73M | 166.85% |
| Dec 31, 2020 | 9.43M | 9.42M | 69,884.41% |
| Dec 31, 2019 | 13.47K | - | - |
| Jun 30, 2018 | - | - | - |
| Jun 30, 2017 | - | - | - |
| Feb 29, 2016 | - | - | - |
| Feb 28, 2015 | - | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| ECO Animal Health Group | 87.53M |
| Kooth | 63.29M |
| hVIVO | 49.66M |
| Shield Therapeutics | 36.93M |
Creo Medical Group News
- 2 months ago - Creo Medical Group sees 50% surge in year-on-year revenues - The Armchair Trader